Reckitt Benckiser shares hit lowest since 2013 on Abbott trial verdict
LONDON (Reuters) – Shares in British consumer goods company Reckitt Benckiser hit their lowest in over 11 years on Monday, after a U.S. jury found Abbott Laboratories formula caused a girl to develop a dangerous bowel disease. The jury found Abbott must pay $495 million in damages. Close to 1,000 lawsuits have been filed against …
Reckitt Benckiser shares hit lowest since 2013 on Abbott trial verdict Read More »